Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

The course, morbidity, and costs of depression.

Klerman GL, Weissman MM.

Arch Gen Psychiatry. 1992 Oct;49(10):831-4. No abstract available.

PMID:
1417437
2.

Are psychological treatments for depression in primary care cost-effective?

Bosmans JE, van Schaik DJ, de Bruijne MC, van Hout HP, van Marwijk HW, van Tulder MW, Stalman WA.

J Ment Health Policy Econ. 2008 Mar;11(1):3-15. Review.

PMID:
18424872
3.

Diagnosis and treatment of depression in general practice.

Freeling P.

Br J Psychiatry Suppl. 1993 Jul;(20):14-9. Review. No abstract available.

PMID:
8352911
4.

The effectiveness of psychotherapy in treating depressive disorders in primary care practice: clinical and cost perspectives.

Schulberg HC, Raue PJ, Rollman BL.

Gen Hosp Psychiatry. 2002 Jul-Aug;24(4):203-12. Review.

PMID:
12100831
5.

Disability from depression: the public health challenge to primary care.

Rost K.

Nord J Psychiatry. 2009;63(1):17-21. doi: 10.1080/08039480802541765. Review.

PMID:
19023696
6.

The costs of depression: direct and indirect; treatment versus nontreatment.

Panzarino PJ Jr.

J Clin Psychiatry. 1998;59 Suppl 20:11-4. Review.

7.

Debits and credits in the management of depression.

Henry JA.

Br J Psychiatry Suppl. 1993 Jul;(20):33-9. Review.

PMID:
8352915
8.

Economic comparisons of the pharmacotherapy of depression: an overview.

Crott R, Gilis P.

Acta Psychiatr Scand. 1998 Apr;97(4):241-52. Review.

PMID:
9570483
9.

The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?

Davidson JR, Meltzer-Brody SE.

J Clin Psychiatry. 1999;60 Suppl 7:4-9; discussion 10-1. Review.

10.

A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression.

Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, Wessely S.

Health Technol Assess. 2001;5(35):1-173. Review. No abstract available.

11.

Pharmacoeconomic considerations when evaluating treatment options for major depressive disorder.

Burke MJ, Silkey B, Preskorn SH.

J Clin Psychiatry. 1994 Sep;55 Suppl A:42-52; discussion 53-4, 98-100. Review.

PMID:
7961542
12.

Side effects, dropouts from treatment and cost consequences.

Montgomery SA, Kasper S.

Int Clin Psychopharmacol. 1998 Feb;13 Suppl 2:S1-5. Review.

PMID:
9669192
13.

[Depression--socioeconomic perspectives].

Sanne B, Dahl AA, Tell GS.

Tidsskr Nor Laegeforen. 2001 Feb 20;121(5):590-5. Review. Norwegian.

PMID:
11301616
14.

Management of depression in patients with coexisting medical illness.

Nesse RE, Finlayson RE.

Am Fam Physician. 1996 May 1;53(6):2125-33. Review. Erratum in: Am Fam Physician 1996 Aug;54(2):468.

PMID:
8623724
15.

[Improving the management of depression in primary care: review and prospects].

Rotgé JY, Tignol J, Aouizerate B.

Encephale. 2007 Sep;33(4 Pt 1):552-60. Review. French.

PMID:
18033142
16.

Side-effects of antidepressants.

Cookson J.

Br J Psychiatry Suppl. 1993 Jul;(20):20-4. Review. No abstract available.

PMID:
8352912
17.

Comparisons of clinical efficacy.

Ferrier IN.

Br J Psychiatry Suppl. 1993 Jul;(20):25-8. Review. No abstract available.

PMID:
8352913
18.

[Cost-Effectiveness of the Treatment of Depression in Old Age].

Bock JO, Brettschneider C, Wegener A, Riedel-Heller S, König HH.

Psychiatr Prax. 2015 Jul;42(5):240-7. doi: 10.1055/s-0034-1387572. Epub 2015 Jun 23. Review. German.

PMID:
26101862
19.

Depressive illness and the possibilities of somatic antidepressant treatment.

Mårtensson B.

Int J Technol Assess Health Care. 1996 Fall;12(4):554-72. Review.

PMID:
9136467
20.

Public health aspects of anxiety and depressive disorders.

Ustün TB, Sartorius N.

Int Clin Psychopharmacol. 1993 Sep;8 Suppl 1:15-20. Review. No abstract available.

PMID:
8254148

Supplemental Content

Support Center